The Open UniversitySkip to content
 

Protection against Ab induces memory loss by tripeptide D-Arg-L-Glu-D-Arg

Mileusnic, R.; Lancashire, C.; Clark, J. and Rose, S. (2007). Protection against Ab induces memory loss by tripeptide D-Arg-L-Glu-D-Arg. In: Iqbal, I.; Wingblat, B. and Avila, J. eds. Alzheimer's Disease: New Advances. Medimond International Proceedings. Bologna, Italy: Medimond, pp. 435–438.

URL: http://www.monduzzi.com/proceedings/moreinfo/20060...
Google Scholar: Look up in Google Scholar

Abstract

The diastomeric (D/L) form of acetylated tripeptide RER protects against A-beta induced memory loss for a passive avoidance task in young chicks and enhances retention for a weak version of the task when injected peripherally up to 12 hr prior to training. The tripeptide readilly crosses the blood-brain barrier, binds to membrane receptor sites in the brain and is whithout adverse effets on general behaviour. RER-related peptides may forma basis for a therapetic agent in the early stages of AD

Item Type: Book Chapter
ISBN: 88-7587-322-4, 978-88-7587-322-6
Extra Information: Alzheimer’s disease (AD) is a major and increasingly prevalent disease in an ageing society, affecting some 12 million people world-wide. Although there are a small number of licensed drugs which are of some utility in alleviating the symptoms of memory loss, it is widely recognised that these are at best palliative. A new approach focussing on different targets is needed if the effects of the disease are to be alleviated and its progression either slowed or prevented. As faulty processing of APP is a key step in the biochemical cascade leading both to plaque formation and the behavioural manifestations of AD, strategies to restore APP’s cell signalling function provide one such new approach for development of a novel therapeutic strategy. Focussing on APP and endeavouring to find ways of restoring its function is based on our observations of the behavioural effect of APP-related tripeptide Arg-Glu-Arg (RER) which not only protects against the amnestic effects of downregulating or functionally blocking APP, but also against the amnestic effect of amyloid beta (A)
Keywords: Alzheimer's disease, memory, enhancment, RER
Academic Unit/Department: Science > Life, Health and Chemical Sciences
Interdisciplinary Research Centre: Biomedical Research Network (BRN)
Item ID: 8234
Depositing User: Radmila Mileusnic
Date Deposited: 27 Jul 2007
Last Modified: 10 Mar 2014 10:30
URI: http://oro.open.ac.uk/id/eprint/8234
Share this page:

Actions (login may be required)

View Item
Report issue / request change

Policies | Disclaimer

© The Open University   + 44 (0)870 333 4340   general-enquiries@open.ac.uk